PVLA

NASD Palvella Therapeutics, Inc.
Oct 5, 2026 · 10:54 PM ET EOD Market Closed

$132.16 ↑ +0.00 (+0.00%) Trading Up from the previous close of $132.16, $1.10 below the day’s high of $133.27

YTD change
+26.26%
vs 20-day SMA
-10.34%
vs 200-day SMA
+6.79%

Price ranges

Previous day
$127.26 $137.04
open $135.15 close $132.47
-$2.68 (-1.98%)
Today
$129.51 $133.27
open $132.50 now $132.16
-$0.34 (-0.26%)
Past week
$127.26 $143.55
from $138.16 now $132.16
-$6.00 (-4.34%)
Past month
$127.26 $160.84
from $155.47 now $132.16
-$23.31 (-14.99%)
This year
$72.23 $161.38
from $104.67 now $132.16
+$27.49 (+26.26%)

Price & Performance

+12.30 (+10.26%) / 6M

$97.71$119.34$140.98$162.61Apr 6Jul 7Oct 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 18.1% away from all-time highs of $161.38
  • PVLA is up 26% since the beginning of the year
  • PVLA is up 101% over the past 12 months
  • PVLA is down 15% over the past 1 month
  • 17% of all PVLA investors are betting against PVLA

PVLA reads not so good: price sits above one of the two key moving averages, the 12-month move is +94.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.52
Earnings momentum +15.4% Quarterly EPS growth
Quarterly change +15.4%

Valuation

P/E ratio N/A
Enterprise value $1.7B
Beta -1.25

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$250.6M
Debt$22.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.1B

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Competitor comparison

TickerCompany PriceChange
ARGNF argenx SE $936.00 -1.62%
GNNSF Genscript Biotech Corporation $5.80 +5.07%
GLXY Galaxy Digital Inc. Class A $22.65 -1.78%
GENSF Genus plc $28.95 +1.56%
CLRPF Clarity Pharmaceuticals Ltd. $1.50 -6.24%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.